Mitraflex

Mitraflex

Wound care A self-adhesive wound dressing for oozing or exudating wounds. See Wound care.
References in periodicals archive ?
Omar Lattouf, was invited by the organizers of the Transcatheter Cardiovascular Therapeutics conference to present the Company's minimally invasive mitral valve repair device, the TransCardiac MitraFlex.
In that study TCT's patented trans-apically placed "stitch and chord," commonly referred to by the proprietary name the TransCardiac MitraFlex, reduced the mitral regurgitant volume from an average of 67% to 39%; which was 18% better and statistically more significant than the Alfieri stitch technique could accomplish.
Lattouf concluded his presentation noting that: (1) TransCardiac's MitraFlex “stitch and chord” may be superior to bow-tie stitch alone; (2) Single or multiple mitral chordal trans-apical replacements are feasible; (3) The TransCardiac MitraFlex may be the surgical minimally invasive alternative to more complex trans septal routes for applying an Alfieri type repair.
of Japan for the marketing of MITRAFLEX polymer-based wound dressings in the Japanese professional healthcare market.
Lee, PolyMedica's chairman and chief executive officer, said, "This is another notable milestone in our goal to increase international distribution of PolyMedica products and marks our entry into the Japanese market with MITRAFLEX.
SPYROFILM expands the application of our 'INTELLIGENT' technology beyond MITRAFLEX and FLEXZAN for use on low exudating wounds.
The company's patented MITRAFLEX and SPYROFLEX moist wound dressings manufactured in Golden, Colo.